Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2021

Open Access 01-12-2021 | Osteoarthrosis | Research article

Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women

Authors: Kai-Leun Tsai, Che-Chang Chang, Yu-Sheng Chang, Yi-Ying Lu, I-Jung Tsai, Jin-Hua Chen, Sheng-Hong Lin, Chih-Chun Tai, Yi-Fang Lin, Hui-Wen Chang, Ching-Yu Lin, Emily Chia-Yu Su

Published in: BMC Medical Informatics and Decision Making | Issue 1/2021

Login to get access

Abstract

Background

Rheumatoid arthritis (RA) is an autoimmune disorder with systemic inflammation and may be induced by oxidative stress that affects an inflamed joint. Our objectives were to examine isotypes of autoantibodies against 4-hydroxy-2-nonenal (HNE) modifications in RA and associate them with increased levels of autoantibodies in RA patients.

Methods

Serum samples from 155 female patients [60 with RA, 35 with osteoarthritis (OA), and 60 healthy controls (HCs)] were obtained. Four novel differential HNE-modified peptide adducts, complement factor H (CFAH)1211–1230, haptoglobin (HPT)78–108, immunoglobulin (Ig) kappa chain C region (IGKC)2–19, and prothrombin (THRB)328–345, were re-analyzed using tandem mass spectrometric (MS/MS) spectra (ProteomeXchange: PXD004546) from RA patients vs. HCs. Further, we determined serum protein levels of CFAH, HPT, IGKC and THRB, HNE-protein adducts, and autoantibodies against unmodified and HNE-modified peptides. Significant correlations and odds ratios (ORs) were calculated.

Results

Levels of HPT in RA patients were greatly higher than the levels in HCs. Levels of HNE-protein adducts and autoantibodies in RA patients were significantly greater than those of HCs. IgM anti-HPT78−108 HNE, IgM anti-IGKC2−19, and IgM anti-IGKC2−19 HNE may be considered as diagnostic biomarkers for RA. Importantly, elevated levels of IgM anti-HPT78−108 HNE, IgM anti-IGKC2−19, and IgG anti-THRB328−345 were positively correlated with the disease activity score in 28 joints for C-reactive protein (DAS28-CRP). Further, the ORs of RA development through IgM anti-HPT78−108 HNE (OR 5.235, p < 0.001), IgM anti-IGKC2−19 (OR 12.655, p < 0.001), and IgG anti-THRB328−345 (OR 5.761, p < 0.001) showed an increased risk. Lastly, we incorporated three machine learning models to differentiate RA from HC and OA, and performed feature selection to determine discriminative features. Experimental results showed that our proposed method achieved an area under the receiver operating characteristic curve of 0.92, which demonstrated that our selected autoantibodies combined with machine learning can efficiently detect RA.

Conclusions

This study discovered that some IgG- and IgM-NAAs and anti-HNE M-NAAs may be correlated with inflammation and disease activity in RA. Moreover, our findings suggested that IgM anti-HPT78−108 HNE, IgM anti-IGKC2−19, and IgG anti-THRB328−345 may play heavy roles in RA development.
Appendix
Available only for authorised users
Literature
1.
go back to reference Quinonez-Flores CM, et al. Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. Biomed Res Int. 2016;2016:6097417.PubMedPubMedCentralCrossRef Quinonez-Flores CM, et al. Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. Biomed Res Int. 2016;2016:6097417.PubMedPubMedCentralCrossRef
2.
go back to reference Kochi Y, et al. Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis. Nat Rev Rheumatol. 2010;6(5):290–5.PubMedCrossRef Kochi Y, et al. Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis. Nat Rev Rheumatol. 2010;6(5):290–5.PubMedCrossRef
3.
go back to reference Kuo CF, et al. Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int. 2013;33(2):355–60.PubMedCrossRef Kuo CF, et al. Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int. 2013;33(2):355–60.PubMedCrossRef
4.
go back to reference Turesson C, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722–7.PubMedPubMedCentralCrossRef Turesson C, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722–7.PubMedPubMedCentralCrossRef
5.
6.
go back to reference Liao CC, et al. Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modified peptide adducts in serum of Taiwanese women with rheumatoid arthritis. J Proteomics. 2018;170:141–50.PubMedCrossRef Liao CC, et al. Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modified peptide adducts in serum of Taiwanese women with rheumatoid arthritis. J Proteomics. 2018;170:141–50.PubMedCrossRef
8.
go back to reference Eggleton P, et al. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med. 2013;57:79–91.PubMedCrossRef Eggleton P, et al. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med. 2013;57:79–91.PubMedCrossRef
9.
go back to reference Jaganjac M, et al. Reactive aldehydes–second messengers of free radicals in diabetes mellitus. Free Radic Res. 2013;47(Suppl 1):39–48.PubMedCrossRef Jaganjac M, et al. Reactive aldehydes–second messengers of free radicals in diabetes mellitus. Free Radic Res. 2013;47(Suppl 1):39–48.PubMedCrossRef
10.
go back to reference Gargiulo S, et al. Oxysterols and 4-hydroxy-2-nonenal contribute to atherosclerotic plaque destabilization. Free Radic Biol Med. 2017;111:140–50.PubMedCrossRef Gargiulo S, et al. Oxysterols and 4-hydroxy-2-nonenal contribute to atherosclerotic plaque destabilization. Free Radic Biol Med. 2017;111:140–50.PubMedCrossRef
11.
go back to reference Zhao J, et al. Mass spectrometric evidence of malonaldehyde and 4-hydroxynonenal adductions to radical-scavenging soy peptides. J Agric Food Chem. 2012;60(38):9727–36.PubMedPubMedCentralCrossRef Zhao J, et al. Mass spectrometric evidence of malonaldehyde and 4-hydroxynonenal adductions to radical-scavenging soy peptides. J Agric Food Chem. 2012;60(38):9727–36.PubMedPubMedCentralCrossRef
12.
go back to reference Lv L, et al. Effect of 4-hydroxy-2-nonenal treatment on the IgE binding capacity and structure of shrimp (Metapenaeus ensis) tropomyosin. Food Chem. 2016;212:313–22.PubMedCrossRef Lv L, et al. Effect of 4-hydroxy-2-nonenal treatment on the IgE binding capacity and structure of shrimp (Metapenaeus ensis) tropomyosin. Food Chem. 2016;212:313–22.PubMedCrossRef
13.
go back to reference Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003;42(4):318–43.PubMedCrossRef Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res. 2003;42(4):318–43.PubMedCrossRef
14.
go back to reference Sayre LM, et al. Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab Rev. 2006;38(4):651–75.PubMedCrossRef Sayre LM, et al. Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab Rev. 2006;38(4):651–75.PubMedCrossRef
16.
go back to reference Binder CJ. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol. 2010;30(Suppl 1):S56-60.PubMedCrossRef Binder CJ. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol. 2010;30(Suppl 1):S56-60.PubMedCrossRef
17.
go back to reference Chou MY, et al. Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008;263(5):479–88.PubMedCrossRef Chou MY, et al. Oxidation-specific epitopes are important targets of innate immunity. J Intern Med. 2008;263(5):479–88.PubMedCrossRef
18.
go back to reference Gronwall C, et al. Depressed serum IgM levels in SLE are restricted to defined subgroups. Clin Immunol. 2017;183:304–315.PubMedCrossRef Gronwall C, et al. Depressed serum IgM levels in SLE are restricted to defined subgroups. Clin Immunol. 2017;183:304–315.PubMedCrossRef
19.
go back to reference Jin H, et al. Oxidatively modified proteins as plasma biomarkers in breast cancer. Cancer Biomark. 2013;13(3):193–200.PubMedCrossRef Jin H, et al. Oxidatively modified proteins as plasma biomarkers in breast cancer. Cancer Biomark. 2013;13(3):193–200.PubMedCrossRef
20.
go back to reference Yokoyama A, et al. Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with menkes kinky hair disease: immunohistochemical study. Yonago Acta Med. 2014;57(1):23–35.PubMedPubMedCentral Yokoyama A, et al. Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with menkes kinky hair disease: immunohistochemical study. Yonago Acta Med. 2014;57(1):23–35.PubMedPubMedCentral
21.
go back to reference Lampka M, et al. Oxidative stress markers during a course of hyperthyroidism. Endokrynol Pol. 2006;57(3):218–22.PubMed Lampka M, et al. Oxidative stress markers during a course of hyperthyroidism. Endokrynol Pol. 2006;57(3):218–22.PubMed
22.
go back to reference Hnat MD, et al. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol. 2005;193(3 Pt 1):836–40.PubMedCrossRef Hnat MD, et al. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol. 2005;193(3 Pt 1):836–40.PubMedCrossRef
23.
go back to reference Uchida K, et al. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry. 1994;33(41):12487–94.PubMedCrossRef Uchida K, et al. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry. 1994;33(41):12487–94.PubMedCrossRef
24.
go back to reference Luczaj W, et al. The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radic Res. 2016;50(3):304–13.PubMedCrossRef Luczaj W, et al. The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radic Res. 2016;50(3):304–13.PubMedCrossRef
25.
go back to reference Wang G, et al. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010;62(7):2064–72.PubMedPubMedCentral Wang G, et al. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010;62(7):2064–72.PubMedPubMedCentral
26.
go back to reference Al-Shobaili HA, et al. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers. 2012;33(1):19–34.PubMedPubMedCentralCrossRef Al-Shobaili HA, et al. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers. 2012;33(1):19–34.PubMedPubMedCentralCrossRef
27.
go back to reference Mottaran E, et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med. 2002;32(1):38–45.PubMedCrossRef Mottaran E, et al. Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med. 2002;32(1):38–45.PubMedCrossRef
28.
go back to reference Takeda A, et al. In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem. 2000;75(3):1234–41.PubMedCrossRef Takeda A, et al. In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem. 2000;75(3):1234–41.PubMedCrossRef
29.
go back to reference Khan F, et al. Unsaturated aldehyde, 4-hydroxynonenal (HNE) alters the structural integrity of HSA with consequences in the immuno-pathology of rheumatoid arthritis. Int J Biol Macromol. 2018;112:306–14.PubMedCrossRef Khan F, et al. Unsaturated aldehyde, 4-hydroxynonenal (HNE) alters the structural integrity of HSA with consequences in the immuno-pathology of rheumatoid arthritis. Int J Biol Macromol. 2018;112:306–14.PubMedCrossRef
30.
go back to reference Aletaha D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.PubMedCrossRef Aletaha D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.PubMedCrossRef
31.
go back to reference Arnett FC, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.PubMedCrossRef Arnett FC, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.PubMedCrossRef
32.
go back to reference Altman R, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33(11):1601–10.PubMedCrossRef Altman R, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33(11):1601–10.PubMedCrossRef
33.
go back to reference Altman R, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–49.PubMedCrossRef Altman R, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–49.PubMedCrossRef
34.
go back to reference Uen YH, et al. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013;83:197–213.PubMedCrossRef Uen YH, et al. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics. 2013;83:197–213.PubMedCrossRef
35.
go back to reference Liao CC, et al. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542–556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjogren’s syndrome and secondary Sjogren’s syndrome in rheumatoid arthritis. J Proteomics. 2016;141:1–11.PubMedCrossRef Liao CC, et al. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542–556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjogren’s syndrome and secondary Sjogren’s syndrome in rheumatoid arthritis. J Proteomics. 2016;141:1–11.PubMedCrossRef
36.
go back to reference Weber D, et al. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol. 2013;1:226–33.PubMedPubMedCentralCrossRef Weber D, et al. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol. 2013;1:226–33.PubMedPubMedCentralCrossRef
37.
go back to reference Fenaille F, Tabet JC, Guy PA. Identification of 4-hydroxy-2-nonenal-modified peptides within unfractionated digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem. 2004;76(4):867–73.PubMedCrossRef Fenaille F, Tabet JC, Guy PA. Identification of 4-hydroxy-2-nonenal-modified peptides within unfractionated digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem. 2004;76(4):867–73.PubMedCrossRef
38.
go back to reference Smith TC, Frank E. Introducing Machine Learning Concepts with WEKA. Methods Mol Biol. 2016;1418:353–78.PubMedCrossRef Smith TC, Frank E. Introducing Machine Learning Concepts with WEKA. Methods Mol Biol. 2016;1418:353–78.PubMedCrossRef
39.
41.
go back to reference Burges CJC. A tutorial on support vector machines for pattern recognition. Data Min Knowl Disc. 1998;2(2):121–67.CrossRef Burges CJC. A tutorial on support vector machines for pattern recognition. Data Min Knowl Disc. 1998;2(2):121–67.CrossRef
42.
go back to reference Pedregosa F, Varoquaux G, Gramfort A, Michel V, et al. Scikit-learn: machine learning in Python. Mach Learn Res. 2011;12:2825–30. Pedregosa F, Varoquaux G, Gramfort A, Michel V, et al. Scikit-learn: machine learning in Python. Mach Learn Res. 2011;12:2825–30.
43.
go back to reference Barrera G, et al. Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxid Redox Signal. 2015;22(18):1681–702.PubMedCrossRef Barrera G, et al. Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxid Redox Signal. 2015;22(18):1681–702.PubMedCrossRef
44.
go back to reference Sokolov AV, et al. Thrombin inhibits the anti-myeloperoxidase and ferroxidase functions of ceruloplasmin: relevance in rheumatoid arthritis. Free Radic Biol Med. 2015;86:279–94.PubMedCrossRef Sokolov AV, et al. Thrombin inhibits the anti-myeloperoxidase and ferroxidase functions of ceruloplasmin: relevance in rheumatoid arthritis. Free Radic Biol Med. 2015;86:279–94.PubMedCrossRef
45.
go back to reference Kumano-Kuramochi M, et al. Identification of 4-hydroxy-2-nonenal–histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem J. 2012a;442(1):171–80.PubMedCrossRef Kumano-Kuramochi M, et al. Identification of 4-hydroxy-2-nonenal–histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem J. 2012a;442(1):171–80.PubMedCrossRef
47.
go back to reference Miller YI, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108(2):235–48.PubMedPubMedCentralCrossRef Miller YI, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108(2):235–48.PubMedPubMedCentralCrossRef
48.
go back to reference Kumano-Kuramochi M, et al. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem J. 2012b;442(1):171–80.PubMedCrossRef Kumano-Kuramochi M, et al. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1. Biochem J. 2012b;442(1):171–80.PubMedCrossRef
49.
go back to reference Chou MY, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest. 2009;119(5):1335–49.PubMedPubMedCentralCrossRef Chou MY, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest. 2009;119(5):1335–49.PubMedPubMedCentralCrossRef
50.
go back to reference Silosi I, et al. The role of autoantibodies in health and disease. Rom J Morphol Embryol. 2016;57(2 Suppl):633–8.PubMed Silosi I, et al. The role of autoantibodies in health and disease. Rom J Morphol Embryol. 2016;57(2 Suppl):633–8.PubMed
51.
go back to reference Adib M, et al. IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol. 1990;145(11):3807–13.PubMedCrossRef Adib M, et al. IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol. 1990;145(11):3807–13.PubMedCrossRef
52.
go back to reference Hurez V, Kaveri S-V, Kazatchkine MD. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol. 1993;23(4):783–9.PubMedCrossRef Hurez V, Kaveri S-V, Kazatchkine MD. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol. 1993;23(4):783–9.PubMedCrossRef
53.
go back to reference Chen Y, et al. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol. 2009;182(10):6031–43.PubMedCrossRef Chen Y, et al. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol. 2009;182(10):6031–43.PubMedCrossRef
55.
56.
go back to reference Foltyn Zadura A, et al. Factor H autoantibodies in patients with antiphospholipid syndrome and thrombosis. J Rheumatol. 2015;42(10):1786–93.PubMedCrossRef Foltyn Zadura A, et al. Factor H autoantibodies in patients with antiphospholipid syndrome and thrombosis. J Rheumatol. 2015;42(10):1786–93.PubMedCrossRef
57.
go back to reference Foltyn Zadura A, et al. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther. 2012;14(4):R185.PubMedPubMedCentralCrossRef Foltyn Zadura A, et al. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther. 2012;14(4):R185.PubMedPubMedCentralCrossRef
58.
60.
go back to reference Trojnar E, et al. Analysis of linear antibody epitopes on factor H and CFHR1 using sera of patients with autoimmune atypical hemolytic uremic syndrome. Front Immunol. 2017;8:302.PubMedPubMedCentralCrossRef Trojnar E, et al. Analysis of linear antibody epitopes on factor H and CFHR1 using sera of patients with autoimmune atypical hemolytic uremic syndrome. Front Immunol. 2017;8:302.PubMedPubMedCentralCrossRef
61.
go back to reference Tan W, et al. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients. Int J Rheum Dis. 2016;19(5):482–9.PubMedCrossRef Tan W, et al. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients. Int J Rheum Dis. 2016;19(5):482–9.PubMedCrossRef
62.
go back to reference Niedermeier W, Cross R, Beetham WP Jr. The concentration of haptoglobin in synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum. 1965;8:355–60.PubMedCrossRef Niedermeier W, Cross R, Beetham WP Jr. The concentration of haptoglobin in synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum. 1965;8:355–60.PubMedCrossRef
63.
go back to reference Yildirim K, et al. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci. 2004;34(4):423–6.PubMed Yildirim K, et al. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci. 2004;34(4):423–6.PubMed
64.
go back to reference Korngold L. The effect of hemoglobin on the haptoglobin-anti-haptoglobin reaction. Immunochemistry. 1965;2(2):103–6.PubMedCrossRef Korngold L. The effect of hemoglobin on the haptoglobin-anti-haptoglobin reaction. Immunochemistry. 1965;2(2):103–6.PubMedCrossRef
65.
go back to reference Carayannopoulos MO, et al. Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scand J Immunol. 2000;51(4):327–36.PubMedCrossRef Carayannopoulos MO, et al. Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scand J Immunol. 2000;51(4):327–36.PubMedCrossRef
67.
go back to reference Das H, et al. Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis. Clin Rheumatol. 2004;23(3):218–22.PubMedCrossRef Das H, et al. Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis. Clin Rheumatol. 2004;23(3):218–22.PubMedCrossRef
68.
go back to reference Newkirk MM, et al. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther. 2003;5(2):R82-90.PubMedPubMedCentralCrossRef Newkirk MM, et al. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther. 2003;5(2):R82-90.PubMedPubMedCentralCrossRef
69.
go back to reference Kern A, et al. Alterations of the thrombin generation profile in rheumatoid arthritis. J Thromb Thrombolysis. 2016;41(3):359–64.PubMedCrossRef Kern A, et al. Alterations of the thrombin generation profile in rheumatoid arthritis. J Thromb Thrombolysis. 2016;41(3):359–64.PubMedCrossRef
70.
go back to reference Tomczyk M, et al. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis. Thromb Res. 2016;143:28–33.PubMedCrossRef Tomczyk M, et al. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis. Thromb Res. 2016;143:28–33.PubMedCrossRef
71.
go back to reference Ohba T, et al. Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor. J Rheumatol. 1996;23(9):1505–11.PubMed Ohba T, et al. Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor. J Rheumatol. 1996;23(9):1505–11.PubMed
72.
go back to reference Yang YH, et al. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology (Oxford). 2010;49(1):34–42.CrossRef Yang YH, et al. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology (Oxford). 2010;49(1):34–42.CrossRef
73.
go back to reference Torres R, Judson-Torres RL. Research Techniques Made Simple: Feature Selection for Biomarker Discovery. J Invest Dermatol. 2019;139(10):2068-2074e1.PubMedCrossRef Torres R, Judson-Torres RL. Research Techniques Made Simple: Feature Selection for Biomarker Discovery. J Invest Dermatol. 2019;139(10):2068-2074e1.PubMedCrossRef
74.
go back to reference Meyer O, et al. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther. 2006;8(2):R40.PubMedPubMedCentralCrossRef Meyer O, et al. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther. 2006;8(2):R40.PubMedPubMedCentralCrossRef
75.
go back to reference Fernandez-Suarez A, et al. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med. 2005;43(11):1234–9.PubMedCrossRef Fernandez-Suarez A, et al. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med. 2005;43(11):1234–9.PubMedCrossRef
76.
go back to reference Sauerland U, et al. Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci. 2005;1050:314–8.PubMedCrossRef Sauerland U, et al. Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci. 2005;1050:314–8.PubMedCrossRef
77.
go back to reference Ates A, Karaaslan Y, Aksaray S. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Clin Rheumatol. 2007;26(4):499–504.PubMedCrossRef Ates A, Karaaslan Y, Aksaray S. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Clin Rheumatol. 2007;26(4):499–504.PubMedCrossRef
Metadata
Title
Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women
Authors
Kai-Leun Tsai
Che-Chang Chang
Yu-Sheng Chang
Yi-Ying Lu
I-Jung Tsai
Jin-Hua Chen
Sheng-Hong Lin
Chih-Chun Tai
Yi-Fang Lin
Hui-Wen Chang
Ching-Yu Lin
Emily Chia-Yu Su
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2021
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-020-01380-y

Other articles of this Issue 1/2021

BMC Medical Informatics and Decision Making 1/2021 Go to the issue